These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 34316638)

  • 1. Parkinson's disease in a patient with multiple sclerosis and heterozygous glucocerebrosidase gene mutation.
    Delalić S; Rus T; Horvat Ledinek A; Kojović M; Georgiev D
    Clin Park Relat Disord; 2020; 3():100055. PubMed ID: 34316638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients.
    Parnetti L; Paciotti S; Eusebi P; Dardis A; Zampieri S; Chiasserini D; Tasegian A; Tambasco N; Bembi B; Calabresi P; Beccari T
    Mov Disord; 2017 Oct; 32(10):1423-1431. PubMed ID: 28843015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene.
    Doppler K; Brockmann K; Sedghi A; Wurster I; Volkmann J; Oertel WH; Sommer C
    Front Neurol; 2018; 9():1094. PubMed ID: 30619053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
    Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
    Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.
    García-Sanz P; Orgaz L; Bueno-Gil G; Espadas I; Rodríguez-Traver E; Kulisevsky J; Gutierrez A; Dávila JC; González-Polo RA; Fuentes JM; Mir P; Vicario C; Moratalla R
    Mov Disord; 2017 Oct; 32(10):1409-1422. PubMed ID: 28779532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease.
    Avenali M; Blandini F; Cerri S
    Front Aging Neurosci; 2020; 12():97. PubMed ID: 32372943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive decline of glucocerebrosidase in aging and Parkinson's disease.
    Rocha EM; Smith GA; Park E; Cao H; Brown E; Hallett P; Isacson O
    Ann Clin Transl Neurol; 2015 Apr; 2(4):433-8. PubMed ID: 25909088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.
    Burbulla LF; Jeon S; Zheng J; Song P; Silverman RB; Krainc D
    Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A severe neurodegenerative disease with Lewy bodies and a mutation in the glucocerebrosidase gene.
    Sipilä JOT; Kytövuori L; Rauramaa T; Rauhamaa H; Kaasinen V; Majamaa K
    NPJ Parkinsons Dis; 2023 Apr; 9(1):53. PubMed ID: 37019925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.
    Rockenstein E; Clarke J; Viel C; Panarello N; Treleaven CM; Kim C; Spencer B; Adame A; Park H; Dodge JC; Cheng SH; Shihabuddin LS; Masliah E; Sardi SP
    Hum Mol Genet; 2016 Jul; 25(13):2645-2660. PubMed ID: 27126635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocerebrosidase as a therapeutic target for Parkinson's disease.
    Chen Y; Sam R; Sharma P; Chen L; Do J; Sidransky E
    Expert Opin Ther Targets; 2020 Apr; 24(4):287-294. PubMed ID: 32106725
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
    Schmid SP; Schleicher ED; Cegan A; Deuschle C; Baur S; Hauser AK; Synofzik M; Srulijes K; Brockmann K; Berg D; Maetzler W
    Mov Disord; 2012 Feb; 27(2):288-92. PubMed ID: 22021190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.
    Chien HF; Rohé CF; Costa MD; Breedveld GJ; Oostra BA; Barbosa ER; Bonifati V
    Neurogenetics; 2006 Mar; 7(1):13-9. PubMed ID: 16328510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
    Martin S; Smolders S; Van den Haute C; Heeman B; van Veen S; Crosiers D; Beletchi I; Verstraeten A; Gossye H; Gelders G; Pals P; Hamouda NN; Engelborghs S; Martin JJ; Eggermont J; De Deyn PP; Cras P; Baekelandt V; Vangheluwe P; Van Broeckhoven C;
    Acta Neuropathol; 2020 Jun; 139(6):1001-1024. PubMed ID: 32172343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous
    Sanyal A; Novis HS; Gasser E; Lin S; LaVoie MJ
    Front Neurosci; 2020; 14():442. PubMed ID: 32499675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.